Sarcoidosis in the Genomic Era: From Genetic Drivers to Tailored Therapies

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences2015 · 92 citations
2. 22018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines2019 · 6,266 citations
3. 3A common haplotype of the C‐C chemokine receptor 2 gene and <i>HLA‐DRB1*0301</i> are independent genetic risk factors for Löfgren’s syndrome2008 · 56 citations
4. 4Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort2020 · 51 citations
5. 5The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis2024 · 4 citations